Please login to the form below

Not currently logged in
Email:
Password:

Pharma product launch

This page shows the latest Pharma product launch news and features for those working in and with pharma, biotech and healthcare.

J&J chief predicts 10 new pharma filings by 2017

J&J chief predicts 10 new pharma filings by 2017

Johnson &Johnson is aiming to break out of the boom/bust cycle often seen in pharma by entering a new product launch phase while still enjoying the benefits of its last ... Speaking during the healthcare giant's fourth-quarter results call yesterday,

Latest news

  • Sanofi plans 18 new product launches by 2020 Sanofi plans 18 new product launches by 2020

    Keen to reinstall faith of investors after firing CEO Viehbacher.  . Sanofi has moved swiftly to reassure investors in the wake of firing chief executive Chris Viehbacher, saying it intends to launch ... The company - which Viehbacher confessed earlier

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest Intelligence

  • Product launches: making the most of your one shot Product launches: making the most of your one shot

    The importance of a pharma product’s launch to its success cannot be overstated. ... of a global product launch is only increasing.

  • How can virtual pharma companies de-risk new product launches? How can virtual pharma companies de-risk new product launches?

    Essentially, they now have to deal with the two main challenges that big pharma has already mastered: getting their product through all the steps to successful market launch, and establishing an ... Yet compliance doesn’t end at product launch. Pharma

  • It started with a miss It started with a miss

    Is pharma finally heading for launch excellence? Chris Ross examines pharma’s never-ending journey to launch excellence and explores what companies can do to ensure their product launches don’t ... Every product is different, so you can’t launch

  • Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe Alnylam’s big moment: bringing groundbreaking RNAi drugs to Europe

    Alnylam's Theresa Heggie. Alnylam and its extraordinary ‘gene silencing’ technology is making its debut in Europe with the launch of Onpattro. ... Going it alone. That means a lot is riding on the early success of Onpattro in the US and Europe, and

More from intelligence
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Bayer’s former oncology head Robert Rosen joins AP Pharma Bayer’s former oncology head Robert Rosen joins AP Pharma

    Will lead launch of drug to prevent chemotherapy-induced nausea. AP Pharma has appointed the former global head of oncology at Bayer Healthcare Robert Rosen as its new senior VP and ... In this role he will lead efforts at the US-based specialty pharma

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Top 5 tips for a multi-indication product launch

    In multi-launch brands, leveraging insights from customers and payers is invaluable for pinpointing the most valuable features of the product and understanding which data is required to shift perceptions. ... investment. Are you planning to launch a new

  • Shionogi Ltd. appoints Star for UK launch

    sales resource to facilitate the launch of a women’s health product in the UK. ... We are excited to be the partner of choice from the early phase of the UK operation and will provide the high-quality individuals desired to ensure a successful product

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dovetail

We’re a specialist health consultancy that supports companies, healthcare professionals and patients to work hand in hand with a common...

Latest intelligence

Virtual meeting technologies for reducing emissions and waste in the healthcare industry
...
Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...